410 Medical Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.09M
- Investors
-
13
410 Medical General Information
Description
Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation. The company's device enhances the speed and efficiency of fluid resuscitation, improves care for patients with life-threatening illnesses such as sepsis and shock, enabling health care providers to easily deliver blood, blood components, crystalloids or colloid fluids.
Contact Information
Website
www.410medical.com
Formerly Known As
410 Medical Innovation
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
- 201 West Main Street
- Suite 207
- Durham, NC 27701
- United States
+1 (919) 000-0000
410 Medical Timeline
410 Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 29-Dec-2021 | $3.09M | 000.00 | Completed | Generating Revenue | |
| 5. Debt - PPP | 28-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A) | 22-Oct-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC | 22-Aug-2018 | 00.00 | 00.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 29-Jun-2017 | $5.35M | $6.45M | 000.00 | Completed | Generating Revenue |
| 1. Seed Round | 13-Jan-2015 | $1.1M | $1.1M | 00.00 | Completed | Generating Revenue |
410 Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Seed | 835,731 | $0.001000 | 8% | $1.46 | $1.46 | 1x | $1.46 | 0.98% |
410 Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation. The company
Other Devices and Supplies
Durham, NC
34
As of 2022
000.00
0000000000 0
000.00
000000
eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
00000000 0000000
Athens, TX
000
As of 0000
000000&0
000000
equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000 000000000
Berlin, Germany
0000
As of 0000
0000
0000-00-00
000000&0
Add Comparison
410 Medical Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| FutureMatrix Interventional | Formerly PE-Backed | Athens, TX | 000 | 000000&0 | ||
| 000000000 | Corporate Backed or Acquired | Berlin, Germany | 0000 | 000000&0 |
410 Medical Patents
410 Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3836985-A4 | Systems, apparatus, and methods for reducing fluid pressure in a fluid line | Pending | 13-Aug-2018 | 00000000 | 0 |
| US-10871788-B2 | Systems, apparatus, and methods for reducing fluid pressure in a fluid line | Active | 13-Aug-2018 | 00000000000 | |
| AU-2019321418-A1 | Systems, apparatus, and methods for reducing fluid pressure in a fluid line | Pending | 13-Aug-2018 | 00000000000 | |
| US-20210325916-A1 | Systems, apparatus, and methods for reducing fluid pressure in a fluid line | Pending | 13-Aug-2018 | 00000000000 | |
| EP-3836985-A1 | Systems, apparatus, and methods for reducing fluid pressure in a fluid line | Pending | 13-Aug-2018 | G05D16/0655 |
410 Medical Executive Team (7)
410 Medical Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Daniel Duffy | Self | Board Member | 000 0000 |
| Jeff Terrell | Hatteras Venture Partners | Board Member | 000 0000 |
| Kyle Chenet | 410 Medical | Chief Executive Officer, President & Board Member | 000 0000 |
| Lukas Roush | Self | Co-Founder & Board Member | 000 0000 |
| Mark Piehl MD | 410 Medical | Co-Founder, Chief Medical Officer & Board Member | 000 0000 |
410 Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
410 Medical Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Sea Purity Investments | Family Office | Minority | 000 0000 | 000000 0 | |
| Hatteras Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| OSF Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Collective Capital Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Kleinheinz Capital Partners | Hedge Fund | Minority | 000 0000 | 000000 0 |